These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36613763)

  • 1. The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components.
    Del Giudice R; Lindvall M; Nilsson O; Monti DM; Lagerstedt JO
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
    Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
    Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
    FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I induced amyloidosis.
    Genschel J; Haas R; Pröpsting MJ; Schmidt HH
    FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
    Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
    Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy Alteration in ApoA-I Related Systemic Amyloidosis.
    Del Giudice R; Imbimbo P; Pietrocola F; Martins I; De Palma FDE; Bravo-San Pedro JM; Kroemer G; Maiuri MC; Monti DM
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I.
    Raimondi S; Guglielmi F; Giorgetti S; Di Gaetano S; Arciello A; Monti DM; Relini A; Nichino D; Doglia SM; Natalello A; Pucci P; Mangione P; Obici L; Merlini G; Stoppini M; Robustelli P; Tartaglia GG; Vendruscolo M; Dobson CM; Piccoli R; Bellotti V
    J Mol Biol; 2011 Apr; 407(3):465-76. PubMed ID: 21296086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the Aggregation of Apolipoprotein A-I.
    Frankel R; Sparr E; Linse S
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-efficient bacterial production of human ApoA-I amyloidogenic variants.
    Del Giudice R; Lagerstedt JO
    Protein Sci; 2018 Dec; 27(12):2101-2109. PubMed ID: 30291643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
    Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
    J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.
    Ramella NA; Schinella GR; Ferreira ST; Prieto ED; Vela ME; Ríos JL; Tricerri MA; Rimoldi OJ
    PLoS One; 2012; 7(8):e43755. PubMed ID: 22952757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
    Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
    J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.
    Morgado I; Panahi A; Burwash AG; Das M; Straub JE; Gursky O
    Biochemistry; 2018 Oct; 57(39):5738-5747. PubMed ID: 30184436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
    Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells.
    Arciello A; De Marco N; Del Giudice R; Guglielmi F; Pucci P; Relini A; Monti DM; Piccoli R
    J Cell Mol Med; 2011 Dec; 15(12):2652-63. PubMed ID: 21306558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis in transgenic mice expressing murine amyloidogenic apolipoprotein A-II (Apoa2c).
    Ge F; Yao J; Fu X; Guo Z; Yan J; Zhang B; Zhang H; Tomozawa H; Miyazaki J; Sawashita J; Mori M; Higuchi K
    Lab Invest; 2007 Jul; 87(7):633-43. PubMed ID: 17468778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity.
    Liz MA; Gomes CM; Saraiva MJ; Sousa MM
    J Lipid Res; 2007 Nov; 48(11):2385-95. PubMed ID: 17693625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux.
    Burgess JW; Kiss RS; Zheng H; Zachariah S; Marcel YL
    J Biol Chem; 2002 Aug; 277(35):31318-26. PubMed ID: 12050168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.